BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9199601)

  • 21. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma.
    Georgiou A; Gomatos IP; Ferekidis E; Syrigos K; Bistola V; Giotakis J; Adamopoulos G; Androulakis G
    Eur J Surg Oncol; 2001 Sep; 27(6):574-80. PubMed ID: 11520092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
    Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?
    Hameed DA; Abdel Raheem AM; Mosad E; Hammouda HM; Kamel NA; Abdel Aziz MA
    Urology; 2008 Aug; 72(2):374-8. PubMed ID: 18342927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of antiapoptotic gene of oral carcinoma by using Bcl-2 oncogene.
    Kummoona R; Mohammad Sámi S; Al-Kapptan I; Al-Muala H
    J Oral Pathol Med; 2008 Jul; 37(6):345-51. PubMed ID: 18248353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck.
    Wang D; Grecula JC; Gahbauer RA; Schuller DE; Jatana KR; Biancamano JD; Lang JC
    Oncol Rep; 2006 Mar; 15(3):661-5. PubMed ID: 16465427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of c-Myc and Bcl-2 protein expression in nasopharyngeal carcinoma.
    Yu Y; Dong W; Li X; Yu E; Zhou X; Li S
    Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1322-6. PubMed ID: 14676159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
    Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
    Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulators of proliferation and apoptosis in carcinoma of the larynx.
    Whisler LC; Wood NB; Caldarelli DD; Hutchinson JC; Panje WR; Friedman M; Preisler HD; Leurgans S; Nowak J; Coon JS
    Laryngoscope; 1998 May; 108(5):630-8. PubMed ID: 9591537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprevention of head and neck cancer with retinoids: a negative result.
    Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
    Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
    Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of bcl-2 and bcl-X in bladder cancer.
    Kirsh EJ; Baunoch DA; Stadler WM
    J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic vessel density in vocal cord carcinomas assessed with LYVE-1 receptor expression.
    Koskinen WJ; Bono P; Leivo I; Vaheri A; Aaltonen LM; Joensuu H
    Radiother Oncol; 2005 Nov; 77(2):172-5. PubMed ID: 16229916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Identification of clinical, biological and prognostic factors in recurring squamous cell carcinoma of the head and neck].
    De Stefani A; Magnano M; Bussi M; Cravero L; Lerda W; Usai A; Cavalot A; Ragona R; Gabriele P; Valente G; Cortesina G
    Acta Otorhinolaryngol Ital; 1997 Jun; 17(3):219-24. PubMed ID: 9489148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.